Thrivent Financial For Lutherans Generation Bio Co. Transaction History

Thrivent Financial For Lutherans

  • $52.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022
SELL
$4.87 - $9.41 $96,601 - $186,656
-19,836 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$4.16 - $7.76 $82,517 - $153,927
19,836 New
19,836 $146,000
Q3 2021

Nov 15, 2021
SELL
$20.0 - $27.43 $220,420 - $302,306
-11,021 Closed
0 $0
Q2 2021

Aug 19, 2021
BUY
$24.34 - $38.34 $268,251 - $422,545
11,021 New
11,021 $296,000

Others Institutions Holding GBIO

# of Institutions
75
Shares Held
49.6M
Call Options Held
0
Put Options Held
0
View Full List

About Generation Bio Co.

GBIO Quotes by TradingView
  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $67.9M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email